Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 16.09% |
| A M R CP | AAMRQ | 9.04% |
| JAZZ PHARMAC | JAZZ | 5.30% |
| DIXIE GROUP | DXYN | 5.59% |
| SANTARUS INC | SNTS | 4.53% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Based on consensus estimates, analysts project 31% EPS growth for Crane this year and 14% growth next year. On top of this, the company pays a dividend that yields 2.2%.
Company Description
Crane Co. manufactures highly engineered industrial products for the aerospace, electronics, hydrocarbon processing, petrochemical, chemical, power generation, automated merchandising, transportation and other markets.
Crane has 5 business segments:
Fluid Handling: 46% of sales
Aerospace & Electronics: 26%
Merchandising Systems: 15%
Engineered Materials: 8%
Controls: 5%
The company was founded in 1855 and has a market cap of $2.7 billion.
Third Quarter Results
Crane reported better than expected results for the third quarter of 2011. Earnings per share came in at 89 cents, beating the Zacks Consensus Estimate by a penny. It was a stellar 27% increase over the same quarter in 2010.
Sales jumped 18% to $659 million, well ahead of the Zacks Consensus Estimate of $634 million. Crane experienced an 11% increase in core sales and benefited 3% from foreign currency effects and 3% from an acquisition.
Except for Engineered Materials, each segment experienced year-over-year sales growth.
Operating profit surged 31% as the company leveraged its fixed expenses. The operating margin improved from 11.2% to 12.5% of sales.
Outlook
Following the strong third quarter, CEO Eric Fast stated that "although there are indications of a slowing global economy, our strengthened portfolio of businesses and broad geographic exposure position us well for profitable growth."
Management also raised the lower end of its earnings guidance range. It now expects 2011 EPS between $3.35 and $3.45 per share. This prompted analysts to revise their estimates higher, sending the stock to a Zacks #2 Rank (Buy).
The Zacks Consensus Estimate for 2011 is $3.40, within guidance, and representing 31% growth over 2010 EPS. The 2012 consensus estimate is now $3.86, corresponding with 14% EPS growth.
Consensus estimates have steadily risen over the last several months as Crane has delivered 7 consecutive positive earnings surprises:
Dividend
On top of strong EPS growth, Crane pays a dividend that yields a solid 2.2%. As you can see, the company has been raising its dividend over the last several years:
Valuation
The valuation picture looks very reasonable for Crane. Shares trade at just 12.2x 12-month forward earnings, in-line with the industry average.
Its price to book ratio of 2.5 is a slight premium to the industry average of 2.3, but this appears to be justified given its superior returns on equity.
The Bottom Line
With strong earnings momentum, solid growth projections, an attractive 2.2% dividend yield and reasonable valuation, Crane offers investors a lot to like.
Todd Bunton is the Growth & Income Stock Strategist for Zacks Investment Research and Co-Editor of the Reitmeister Value Investor.
Read the full reports :
Snapshot Report on CR